BERTANI, LORENZO Statistiche

BERTANI, LORENZO  

DIPARTIMENTO DI RICERCA TRASLAZIONALE E DELLE NUOVE TECNOLOGIE IN MEDICINA E CHIRURGIA  

Mostra records
Risultati 1 - 20 di 68 (tempo di esecuzione: 0.045 secondi).
Titolo Data di pubblicazione Autore(i) File
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 1-gen-2020 Saibeni, S.; Scucchi, L.; Dragoni, G.; Bezzio, C.; Miranda, A.; Ribaldone, D. G.; Bertani, A.; Bossa, F.; Allocca, M.; Buda, A.; Mocci, G.; Soriano, A.; Mazzuoli, S.; Bertani, L.; Baccini, F.; Loddo, E.; Privitera, A. C.; Sartini, A.; Viscido, A.; Grossi, L.; Casini, V.; Gerardi, V.; Ascolani, M.; Ruscio, M. D.; Casella, G.; Savarino, E.; Stradella, D.; Pumpo, R.; Cortelezzi, C. C.; Daperno, M.; Ciardo, V.; Nardone, O. M.; Caprioli, F.; Vitale, G.; Cappello, M.; Comberlato, M.; Alvisi, P.; Festa, S.; Campigotto, M.; Bodini, G.; Balestrieri, P.; Viola, A.; Pugliese, D.; Armuzzi, A.; Fantini, M. C.; Fiorino, G.
Adalimumab biosimilars, ABP501 and SB5, are equally effective and safe as adalimumab originator 1-gen-2021 Cingolani, L.; Barberio, B.; Zingone, F.; Ferronato, A.; Bertani, L.; Costa, F.; Bodini, G.; Demarzo, M. G.; Melatti, P.; Gubbiotti, A.; Massimi, D.; Casadei, C.; D'Inca, R.; Savarino, E. V.
The Adherence to Infusible Biologic Therapies in Inflammatory Bowel Disease Patients during the COVID-19 Pandemic: Is It Really a Problem? 1-gen-2021 Barberio, B.; Zingone, F.; Bertani, L.; Savarino, E.
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) 1-gen-2021 Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Blandizzi, C; Lucenteforte, E; Gini, R; Tuccori, M
Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis 1-gen-2022 D'Antongiovanni, Vanessa; Pellegrini, Carolina; Benvenuti, Laura; Fornai, Matteo; Di Salvo, Clelia; Natale, Gianfranco; Ryskalin, Larisa; Bertani, Lorenzo; Lucarini, Elena; Di Cesare Mannelli, Lorenzo; Ghelardini, Carla; Nemeth, Zoltan H; Haskó, György; Antonioli, Luca
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 1-gen-2019 Savarino, E.; Bertani, L.; Ceccarelli, L.; Bodini, G.; Zingone, F.; Buda, A.; Facchin, S.; Lorenzon, G.; Marchi, S.; Marabotto, E.; De Bortoli, N.; Savarino, V.; Costa, F.; Blandizzi, C.
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn’s disease: pharmacological and clinical implications 1-gen-2019 Savarino, Edoardo; Bertani, Lorenzo; Ceccarelli, Linda; Bodini, Giorgia; Zingone, Fabiana; Buda, Andrea; Facchin, Sonia; Lorenzon, Greta; Marchi, Santino; Marabotto, Elisa; De Bortoli, Nicola; Savarino, Vincenzo; Costa, Francesco; Blandizzi, Corrado
Are PPI responder patients always confirmed as GERD patients? A MII-PH study. 1-gen-2012 DE BORTOLI, Nicola; Martinucci, I.; Savarino, E.; Bolognesi, V.; Ussia, V.; Bertani, L.; Racale, C.; Frattino, A.; Bellini, M.; Marchi, Santino
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 1-gen-2020 Bertani, L.; Baglietto, L.; Antonioli, L.; Fornai, M.; Tapete, G.; Albano, E.; Ceccarelli, L.; Mumolo, M. G.; Pellegrini, C.; Lucenteforte, E.; de Bortoli, N.; Bellini, M.; Marchi, S.; Blandizzi, C.; Costa, F.
Barrett's esophagus in 2016: From pathophysiology to treatment 1-gen-2016 Martinucci, Irene; DE BORTOLI, Nicola; Russo, Salvatore; Bertani, Lorenzo; Furnari, Manuele; Mokrowiecka, Anna; Malecka Panas, Ewa; Savarino, Vincenzo; Savarino, Edoardo; Marchi, Santino
The complex interplay between gastrointestinal and psychiatric symptoms in irritable bowel syndrome: A longitudinal assessment 1-gen-2018 Stasi, Cristina; Caserta, Anna; Nisita, Cristiana; Cortopassi, Sonia; Fani, Bernardo; Salvadori, Stefano; Pancetti, Andrea; Bertani, Lorenzo; Gambaccini, Dario; de Bortoli, Nicola; Dell'Osso, Liliana; Blandizzi, Corrado; Marchi, Santino; Bellini, Massimo
Corticosteroid Treatment at Diagnosis: An Analysis of Relapses, Disease Extension, and Colectomy Rate in Ulcerative Colitis 1-gen-2019 Bertani, L.; Bodini, G.; Mumolo, M. G.; de Bortoli, N.; Ceccarelli, L.; Frazzoni, L.; Tapete, G.; Albano, E.; Plaz Torres, M. C.; Bellini, M.; Savarino, E.; Savarino, V.; Marchi, S.; Costa, F.; Bellini, Massimo
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 1-gen-2021 Ferraro, S; Bartolini, C; Convertino, I; Bertani, L; Giometto, S; Cappello, E; Valdiserra, G; Tillati, S; Blandizzi, C; Lucenteforte, E; Costa, F; Gini, R; Tuccori, M
Early vedolizumab trough levels predict treatment persistence over the first year in inflammatory bowel disease 1-gen-2019 Guidi, L.; Pugliese, D.; Tonucci, T. P.; Bertani, L.; Costa, F.; Privitera, G.; Tolusso, B.; Di Mario, C.; Albano, E.; Tapete, G.; Gremese, E.; Papa, A.; Gasbarrini, A.; Rapaccini, G. L.; Armuzzi, A.
Editorial: can serum triiodothyronine-to-thyroxine (T3/T4) ratio predict safety and efficacy of biologic treatment in IBD? Authors' reply 1-gen-2020 Bertani, L.; Pugliese, D.; Trico, D.; Costa, F.; Blandizzi, C.
Editorial: serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab—authors' reply 1-gen-2020 Bertani, L.; Fornai, M.; Antonioli, L.; Blandizzi, C.
Editorial: serum triiodothyronine-to-thyroxine (T3/T4) ratio as biomarker of response in IBD - an open issue 1-gen-2022 Bertani, Lorenzo; Tricò, Domenico
Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial 1-gen-2018 Cremon, Cesare; Guglielmetti, Simone; Gargari, Giorgio; Taverniti, Valentina; Castellazzi, Anna Maria; Valsecchi, Chiara; Tagliacarne, Carlotta; Fiore, Walter; Bellini, Massimo; Bertani, Lorenzo; Gambaccini, Dario; Cicala, Michele; Germanà, Bastianello; Vecchi, Maurizio; Pagano, Isabella; Barbaro, Maria Raffaella; Bellacosa, Lara; Stanghellini, Vincenzo; Barbara, Giovanni
Effectiveness and Safety of Nonmedical Switch From Adalimumab Originator to SB5 Biosimilar in Patients With Inflammatory Bowel Diseases: Twelve-Month Follow-Up From the TABLET Registry 1-gen-2022 Tapete, Gherardo; Bertani, Lorenzo; Pieraccini, Alberto; Lynch, Erica Nicola; Giannotta, Martina; Morganti, Riccardo; Biviano, Ivano; Naldini, Sara; Mumolo, Maria Gloria; De Nigris, Francesca; Calella, Francesca; Bagnoli, Siro; Minciotti, Moira; Maltinti, Simona; Rentini, Silvia; Ceccarelli, Linda; Lionetti, Paolo; Milla, Monica; Costa, Francesco
Eosinophilic esophagitis: clinical, endoscopic, histologic and therapeutic differences and similarities between children and adults 1-gen-2021 Visaggi, P.; Savarino, E.; Sciume, G.; Chio, T. D.; Bronzini, F.; Tolone, S.; Frazzoni, M.; Pugno, C.; Ghisa, M.; Bertani, L.; Bellini, M.; Savarino, V.; Peroni, D.; Marchi, S.; de Bortoli, N.